Augustine Asset Management Inc
Source: SEC Form 13F · as of Mar 2026Augustine Asset Management Inc holds 11 biotech & pharma companies tracked by BioSniper, totaling $35.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$35.0M
| Company | Shares | Value |
|---|---|---|
| MRKMerck & Co., Inc. | 73,215 | $8.8M |
| GILDGILEAD SCIENCES, INC. | 48,933 | $6.8M |
| UTHRUNITED THERAPEUTICS Corp | 5,973 | $3.5M |
| RDYDR REDDYS LABORATORIES LTD | 250,250 | $3.5M |
| REGNREGENERON PHARMACEUTICALS, INC. | 4,479 | $3.5M |
| AMGNAMGEN INC | 7,302 | $2.6M |
| SNYSanofi | 44,975 | $2.2M |
| NVONovo Nordisk A/S | 34,793 | $1.3M |
| LLYELI LILLY & Co | 1,270 | $1.2M |
| CAHCardinal Health Inc. | 4,292 | $907K |
| JNJJOHNSON & JOHNSON | 3,503 | $856K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.